U.S. and China Trade War, and Why Experts Disagree on its Impact

 

The ongoing trade war between the United States and China continues to make an impact on businesses even beyond the two nations’ borders.

U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin are currently meeting with Chinese diplomats in Shanghai to find a resolution. Until an agreement is reached though, businesses and consumers will continue to deal with the uncertainty.

“I don’t think there’s much optimism, or I’m pretty sure there is no optimism, that this round of talks is going to get very far,” Southern Methodist University Associate Professor of Economics James Lake said.

The nations announced a deal was imminent just months ago, but both sides have tempered expectations since the breakdown of the last round of talks. With no resolution in plain view, Lake says businesses reliant on Chinese imports or exports can hunker down and wait for the results of the 2020 U.S. presidential election, or make a significant shift away from China to mitigate any further tariffs.

“Given the uncertainty about the trade war happening in China and also the Chinese market perhaps not being as attractive as it has in the recent past in terms of labor cost, now could be the time to potentially think about moving the supply chain out of China to somewhere else,” Lake said.

The solutions to this uncertainty in the meantime depends on individuals’ circumstances and businesses are approaching this differently, according to Phil Levy, Chief Economist at Flexport, a San Francisco-based digital freight forwarder.

“You see companies sort of able to shift in some cases to products which have not yet been hit by tariffs. You also see companies to some extent rework their supply chain to avoid these tariffs, which for the most part have applied to direct trade between China and the United States, so we see some preliminary evidence of both,” Levy said. “We also see that companies are simply paying a lot of money in tariffs.”

Only time will tell how the trade war comes to a ceasefire, but for businesses that need to make investments presently, their futures will be defined by their decisions today.

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More